Mealey's (October 28, 2019, 1:29 PM EDT) -- TRENTON, N.J. — Efforts by several generic drug makers to recoup the attorney fees they incurred in successfully defending allegations of patent infringement failed Oct. 25, when a federal judge in...
In New Jersey, Patent Defendants’ Bid For Attorney Fees Denied
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login